Is Lenalidomide a chemotherapy drug?

Lenalidomide (Lenalidomide) is not a traditional chemotherapy drug, but an immunomodulatory drug that is often classified as a targeted therapy. Although lenalidomide is used to treat malignant hematological diseases such as multiple myeloma, its mechanism of action and use are very different from traditional chemotherapy drugs.

The main function of lenalidomide is to treat diseases by regulating the immune system, inhibiting the growth of tumor cells and promoting the activity of the immune system. It has specific molecular targets that primarily affect the immune system and tumor cells in the bone marrow to reduce cancer progression and improve patient survival. This is different from the mechanism of action of traditional chemotherapy drugs, which usually directly kill tumor cells by interfering with cell division and killing rapidly proliferating cells.

Thus, lenalidomide is closer to a targeted therapy drug, which targets specific molecules or cellular processes to more precisely influence tumor growth and the immune system's response. It is often used together with other drugs in the treatment of malignant hematological diseases to provide more effective treatment strategies and has achieved remarkable success in clinical practice. However, it needs to be emphasized that although lenalidomide is different from traditional chemotherapy drugs, it may still cause some side effects and needs to be used and managed correctly under the supervision of a doctor.

Lenalidomide has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price is around 3,500~4,000 yuan. Due to different medical insurance policies in various places, the price also varies. Please consult your local pharmacy for specific prices. There are also original research drugs in China, but the price is as high as tens of thousands of yuan, so it is not recommended to buy them. The cheaper ones abroad are mainly generic drugs, including those from India, Bangladesh, and Laos, which cost about a few hundred yuan per box. The ingredients of foreign generic drugs and domestic lenalidomide drugs are basically the same.